NCT03533413

Brief Summary

In the current study, extra-guidance other than conventional fluoroscopy - will be integrated to improve the success of the transforaminal approach to the thoracic dorsal root ganglia (DRG). The investigators hypothesize that joining CT scan with fluoroscopy to guide RF ablation through the transforaminal route may enhance its efficacy and safety in relieving the intractable pain associated with chest malignancies. The current study aimed to compare the results of thermal radiofrequency ablation (TRFA) of the thoracic DRG under combined CT and fluoroscopy guidance with the classic standard fluoroscopy technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 23, 2018

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

7 months

First QC Date

April 22, 2018

Last Update Submit

May 25, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain relief.

    Pain intensity measured by visual analog scale (VAS).It measures the pain intensity and percentage of pain relief.The investigators used 100 mm horizontal scale with left zero end representing no pain and right 100 end representing worst pain.Scores ranging 0-39 reflect mild pain , 40-69 moderate pain and 70-100 severe pain.

    12 weeks follow up

Secondary Outcomes (1)

  • patient satisfaction.

    12 weeks

Study Arms (2)

Interventional:Combined CT-fluroscopy

ACTIVE COMPARATOR

Combined CT-fluroscopic radiofrequency ablation of thoracic dorsal root ganglia.

Procedure: combined CT-fluroscopy

Interventional: standard fluroscopy

ACTIVE COMPARATOR

Fluroscopic radiofrequency ablation of thoracic dorsal root ganglia.

Procedure: standard fluroscopy

Interventions

Radiofrequency ablation of thoracic dorsal root ganglia guided by combined CT-Fluroscopy

Interventional:Combined CT-fluroscopy

Radiofrequency ablation of thoracic dorsal root ganglia guided by standard fluroscopy only

Interventional: standard fluroscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients aged 18 years or more
  • suffering from chronic moderate-to-severe pain ( VAS score ≥ 40 mm)
  • due to malignancy involving the chest and pain was refractory to the maximally tolerated dose of opioids for at least four weeks. Malignancies included : lung cancer, pleural mesothelioma, chest wall tumors and metastatic deposits of the chest.

You may not qualify if:

  • sepsis, coagulopathy
  • malignant epidural invasion
  • distorted local anatomy
  • severe cardiorespiratory compromise
  • neuropsychiatric illness
  • history of drug dependence and known allergy to contrast media or the used medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia and Pain medicine.National Cancer Institute

Cairo, 11796, Egypt

Location

Related Publications (1)

  • Reyad RM, Ghobrial HZ, Shaker EH, Reyad EM, Shaaban MH, Hashem RH, Darwish WM. Modified technique for thermal radiofrequency ablation of Thoracic dorsal root ganglia under combined fluoroscopy and CT guidance: a randomized clinical trial. BMC Anesthesiol. 2019 Dec 18;19(1):234. doi: 10.1186/s12871-019-0906-4.

Related Links

Study Officials

  • Ehab H Shaker, MD

    National Cancer Institute- Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesia ,critical care and pain medicine

Study Record Dates

First Submitted

April 22, 2018

First Posted

May 23, 2018

Study Start

April 1, 2017

Primary Completion

October 31, 2017

Study Completion

November 30, 2017

Last Updated

May 30, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

It will be a shared team work study during which all the investigators will have equally distributed roles.

Locations